View Author
scopus: 7004865608

Berenguer, A.

(Antonio Berenguer)


screening contamination erspc cancer study european randomised study prostate cancer control arm prostate death nonattendance randomised centre european control analysis mortality rotterdam cohort men randomised pca deaths psa test effect reduction urology randomisation adjustment erspc rotterdam psa testing mortality reduction noconsent psa use noncompliance t-stage distribution department cuzick testing screening arm roobol group estimate trial result antigen extrapolation pca cases number schroder method university intervention arm consent screening round yesconsent erspc study cohort contaminator 584–591 screening purposes stage analyses t stage t-stage distribution hospital intervention prostate-specific finland tampere kerkhof subcohort tampere university hospital roobol mj purpose erasmus mc prostate cancer screening grant follow-up erspc section rotterdam correction psa-based screening




1 Most Recent Publications

Prostate Cancer Mortality Reduction by Prostate-Specific Antigen-Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC) (Article)
Roobol, M.J. Kerkhof, M. Lujan, M. Lilja, H. Zappa, M. Denis, L.J. Recker, F. Berenguer, A. Ruutu, M. Kujala, P.M. Bangma, C.H. Aus, G. Schröder, F.H. Tammela, T.L. Villers, A. Rébillard, X. Moss, S.M. Koning, H.J. de Hugosson, J. Auvinen, A. Cuzick, J. Sasieni, P. Hakama, M. Stenman, U.H. Ciatto, S. Nelen, V. Kwiatkowski, M.
2009-10-01